StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
RBC Capital Upgrades Chemours (CC) to Outperform; 'TT recovery and TSS strength'
November 30, 2023 4:57 PM
RBC Capital analyst Arun Viswanathan upgraded Chemours (NYSE: CC) from Sector Perform to Outperform with a price target of $40.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Upgrades
Upgrades
Next Articles
Chemours (CC) lifted at RBC Capital on TiO2 margin recovery
December 1, 2023 11:18 AM